Logo image of ALKLK.PA

KERLINK (ALKLK.PA) Stock Fundamental Analysis

Europe - Euronext Paris - EPA:ALKLK - FR0013156007 - Common Stock

0.904 EUR
-0.02 (-1.74%)
Last: 11/21/2025, 7:00:00 PM
Fundamental Rating

2

Taking everything into account, ALKLK scores 2 out of 10 in our fundamental rating. ALKLK was compared to 29 industry peers in the Communications Equipment industry. ALKLK has a bad profitability rating. Also its financial health evaluation is rather negative. ALKLK is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year ALKLK has reported negative net income.
ALKLK had a positive operating cash flow in the past year.
In the past 5 years ALKLK always reported negative net income.
In multiple years ALKLK reported negative operating cash flow during the last 5 years.
ALKLK.PA Yearly Net Income VS EBIT VS OCF VS FCFALKLK.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5M -10M

1.2 Ratios

The Return On Assets of ALKLK (-16.25%) is worse than 79.31% of its industry peers.
ALKLK has a Return On Equity of -92.45%. This is amonst the worse of the industry: ALKLK underperforms 82.76% of its industry peers.
Industry RankSector Rank
ROA -16.25%
ROE -92.45%
ROIC N/A
ROA(3y)-14.32%
ROA(5y)-15.26%
ROE(3y)-59.86%
ROE(5y)-55.52%
ROIC(3y)N/A
ROIC(5y)N/A
ALKLK.PA Yearly ROA, ROE, ROICALKLK.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -100 -200 -300 -400

1.3 Margins

ALKLK's Gross Margin of 28.97% is on the low side compared to the rest of the industry. ALKLK is outperformed by 86.21% of its industry peers.
In the last couple of years the Gross Margin of ALKLK has declined.
The Profit Margin and Operating Margin are not available for ALKLK so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 28.97%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.77%
GM growth 5Y-8.4%
ALKLK.PA Yearly Profit, Operating, Gross MarginsALKLK.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

2

2. Health

2.1 Basic Checks

ALKLK does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALKLK has less shares outstanding
ALKLK has more shares outstanding than it did 5 years ago.
The debt/assets ratio for ALKLK is higher compared to a year ago.
ALKLK.PA Yearly Shares OutstandingALKLK.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
ALKLK.PA Yearly Total Debt VS Total AssetsALKLK.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

ALKLK has an Altman-Z score of 0.81. This is a bad value and indicates that ALKLK is not financially healthy and even has some risk of bankruptcy.
ALKLK has a worse Altman-Z score (0.81) than 65.52% of its industry peers.
The Debt to FCF ratio of ALKLK is 5.10, which is a neutral value as it means it would take ALKLK, 5.10 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 5.10, ALKLK perfoms like the industry average, outperforming 41.38% of the companies in the same industry.
ALKLK has a Debt/Equity ratio of 2.13. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 2.13, ALKLK is doing worse than 75.86% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 2.13
Debt/FCF 5.1
Altman-Z 0.81
ROIC/WACCN/A
WACC4.79%
ALKLK.PA Yearly LT Debt VS Equity VS FCFALKLK.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

2.3 Liquidity

ALKLK has a Current Ratio of 1.90. This is a normal value and indicates that ALKLK is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 1.90, ALKLK is doing good in the industry, outperforming 62.07% of the companies in the same industry.
ALKLK has a Quick Ratio of 1.90. This is a bad value and indicates that ALKLK is not financially healthy enough and could expect problems in meeting its short term obligations.
ALKLK has a worse Quick ratio (0.88) than 79.31% of its industry peers.
Industry RankSector Rank
Current Ratio 1.9
Quick Ratio 0.88
ALKLK.PA Yearly Current Assets VS Current LiabilitesALKLK.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

4

3. Growth

3.1 Past

ALKLK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 25.13%, which is quite impressive.
The Revenue has decreased by -4.86% in the past year.
ALKLK shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.20% yearly.
EPS 1Y (TTM)25.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%41.56%
Revenue 1Y (TTM)-4.86%
Revenue growth 3Y-16.27%
Revenue growth 5Y-2.2%
Sales Q2Q%16.18%

3.2 Future

The Earnings Per Share is expected to grow by 34.10% on average over the next years. This is a very strong growth
ALKLK is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 22.13% yearly.
EPS Next Y50.98%
EPS Next 2Y38.62%
EPS Next 3Y34.1%
EPS Next 5YN/A
Revenue Next Year16.28%
Revenue Next 2Y21.36%
Revenue Next 3Y22.13%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALKLK.PA Yearly Revenue VS EstimatesALKLK.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5M 10M 15M 20M
ALKLK.PA Yearly EPS VS EstimatesALKLK.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -0.5 -1

2

4. Valuation

4.1 Price/Earnings Ratio

ALKLK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year ALKLK is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALKLK.PA Price Earnings VS Forward Price EarningsALKLK.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20 30

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, ALKLK is valued cheaply inside the industry as 89.66% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 2.71
EV/EBITDA N/A
ALKLK.PA Per share dataALKLK.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

A more expensive valuation may be justified as ALKLK's earnings are expected to grow with 34.10% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.62%
EPS Next 3Y34.1%

0

5. Dividend

5.1 Amount

No dividends for ALKLK!.
Industry RankSector Rank
Dividend Yield N/A

KERLINK

EPA:ALKLK (11/21/2025, 7:00:00 PM)

0.904

-0.02 (-1.74%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryCommunications Equipment
Earnings (Last)10-14 2025-10-14
Earnings (Next)04-22 2026-04-22
Inst Owners11.59%
Inst Owner ChangeN/A
Ins Owners5.6%
Ins Owner ChangeN/A
Market Cap6.75M
Revenue(TTM)12.68M
Net Income(TTM)-3.77M
Analysts40
Price Target1.12 (23.89%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)30.56%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.58
P/FCF 2.71
P/OCF 1.88
P/B 1.65
P/tB 6.93
EV/EBITDA N/A
EPS(TTM)-0.4
EYN/A
EPS(NY)-0.04
Fwd EYN/A
FCF(TTM)0.33
FCFY36.93%
OCF(TTM)0.48
OCFY53.27%
SpS1.56
BVpS0.55
TBVpS0.13
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -16.25%
ROE -92.45%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 28.97%
FCFM 21.38%
ROA(3y)-14.32%
ROA(5y)-15.26%
ROE(3y)-59.86%
ROE(5y)-55.52%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.77%
GM growth 5Y-8.4%
F-Score5
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 2.13
Debt/FCF 5.1
Debt/EBITDA N/A
Cap/Depr 62.14%
Cap/Sales 9.45%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.9
Quick Ratio 0.88
Altman-Z 0.81
F-Score5
WACC4.79%
ROIC/WACCN/A
Cap/Depr(3y)95.64%
Cap/Depr(5y)79.23%
Cap/Sales(3y)11.29%
Cap/Sales(5y)9.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)25.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%41.56%
EPS Next Y50.98%
EPS Next 2Y38.62%
EPS Next 3Y34.1%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.86%
Revenue growth 3Y-16.27%
Revenue growth 5Y-2.2%
Sales Q2Q%16.18%
Revenue Next Year16.28%
Revenue Next 2Y21.36%
Revenue Next 3Y22.13%
Revenue Next 5YN/A
EBIT growth 1Y1.73%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year100%
EBIT Next 3Y45.25%
EBIT Next 5YN/A
FCF growth 1Y774.05%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y190.32%
OCF growth 3YN/A
OCF growth 5YN/A

KERLINK / ALKLK.PA FAQ

Can you provide the ChartMill fundamental rating for KERLINK?

ChartMill assigns a fundamental rating of 2 / 10 to ALKLK.PA.


What is the valuation status of KERLINK (ALKLK.PA) stock?

ChartMill assigns a valuation rating of 2 / 10 to KERLINK (ALKLK.PA). This can be considered as Overvalued.


What is the profitability of ALKLK stock?

KERLINK (ALKLK.PA) has a profitability rating of 1 / 10.


How financially healthy is KERLINK?

The financial health rating of KERLINK (ALKLK.PA) is 2 / 10.


What is the earnings growth outlook for KERLINK?

The Earnings per Share (EPS) of KERLINK (ALKLK.PA) is expected to grow by 50.98% in the next year.